Literature DB >> 1649288

Effect of calcium/phosphorus ratio on mineral retention in parenterally fed premature infants.

J F Pelegano1, J C Rowe, D E Carey, D J LaBarre, K W Edgren, A M Lazar, E Horak.   

Abstract

We hypothesized that retention of parenterally delivered calcium (Ca) and phosphorus (P) is affected by the ratio of the delivered minerals and that a 1.7:1 ratio would be optimal since this is the ratio of retention of these minerals by the fetus. Forty-one very low birth weight (VLBW) infants were randomly assigned to one of three total parenteral nutrition (TPN) solutions that were different only in their Ca:P ratios: 2:1 (76 mg/kg/day Ca and 38 mg/kg/day of P), and 1.3:1 (58 mg/kg/day Ca and 45 mg/kg/day P), and 1.3:1 (58 mg/kg/day of Ca and 45 mg/kg/day of P). Serum levels of calcium, phosphorus, and alkaline phosphatase, retentions of calcium and phosphorus and urinary cyclic AMP levels were measured after 48 h on the assigned Ca to P ratio. Calcium retentions were higher with the 2:1 and 1.7:1 ratios and phosphorus retentions were higher with the 1.3:1 and 1.7:1 ratios. The 1.7:1 ratio allowed for the highest absolute retention of both minerals and was the closest to published in utero accretion of calcium and phosphorus. The serum and urine studies demonstrated no abnormalities on any of the three ratios. Cyclic AMPs were not different among groups and were not elevated compared to previous reports suggesting that none resulted in parathyroid hormone (PTH) stimulation. We conclude that the 1.7:1 ratio is better than higher or lower ratios for delivery of calcium and phosphorus in TPN solutions at the quantities studied.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649288     DOI: 10.1097/00005176-199104000-00011

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  5 in total

1.  Improving Pediatric Outcomes through Intravenous and Oral Medication Standardization.

Authors:  Mark W Mackay; Jared Cash; Fred Farr; Marc Holley; Kevin Jones; Sabrina Boehme
Journal:  J Pediatr Pharmacol Ther       Date:  2009-10

2.  Metabolic bone disease in the preterm infant: Current state and future directions.

Authors:  Moghis Ur Rehman; Hassib Narchi
Journal:  World J Methodol       Date:  2015-09-26

3.  Experience of compounding total parenteral nutrition admixtures for preterm infants in a hospital pharmacy: evidence of calcium and phosphate compatibility problem.

Authors:  Davide Zenoni; Stefano Loiacono
Journal:  Eur J Hosp Pharm       Date:  2017-01-11

4.  Screening of Serum Alkaline Phosphatase and Phosphate Helps Early Detection of Metabolic Bone Disease in Extremely Low Birth Weight Infants.

Authors:  Hui Zhang; Qiong Jia; Meihua Piao; Yanmei Chang; Jinghui Zhang; Xiaomei Tong; Tongyan Han
Journal:  Front Pediatr       Date:  2021-04-22       Impact factor: 3.418

Review 5.  Metabolic bone disease of prematurity.

Authors:  Stacy E Rustico; Andrew C Calabria; Samuel J Garber
Journal:  J Clin Transl Endocrinol       Date:  2014-07-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.